Metabolic dependencies of acute myeloid leukemia stem cells

被引：1

作者：

Shi, Xiangguo ^{[1
,2
]}

Feng, Mengdie ^{[1
]}

Nakada, Daisuke ^{[1
]}

机构：

[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA

[2] Penn State Univ, Coll Med, Dept Pediat, Div Pediat Hematol Oncol, Hershey, PA 16801 USA

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 2024年 / 120卷 / 04期

关键词：

Acute myeloid leukemia; Leukemia stem cell; Metabolic regulation; AMINO-ACID-METABOLISM; OXIDATIVE-PHOSPHORYLATION; SELF-RENEWAL; GLUCOSE-METABOLISM; INHIBITION; CHEMOTHERAPY; RESISTANCE; VENETOCLAX; THERAPY; NAMPT;

D O I：

10.1007/s12185-024-03789-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy primarily driven by an immature population of AML cells termed leukemia stem cells (LSCs) that are implicated in AML development, chemoresistance, and relapse. An emerging area of research in AML focuses on identifying and targeting the aberrant metabolism in LSCs. Dysregulated metabolism is involved in sustaining functional properties of LSCs, impeding myeloid differentiation, and evading programmed cell death, both in the process of leukemogenesis and in response to chemotherapy. This review discusses recent discoveries regarding the aberrant metabolic processes of AML LSCs that have begun to change the therapeutic landscape of AML.

引用

页码：427 / 438

页数：12

共 50 条

[11] Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
Feng, Lili
Zhang, Philip Y.
Gao, Wenda
Yu, Jinming
Robson, Simon C.
FRONTIERS IN ONCOLOGY, 2023, 13
[12] Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications
Long, Nathaniel A.
Golla, Upendarrao
Sharma, Arati
Claxton, David F.
STEM CELL REVIEWS AND REPORTS, 2022, 18 (04) : 1211 - 1226
[13] Acute myeloid leukemia stem cells: seek and destroy
Roboz, Gail J.
Guzman, Monica
EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (06) : 663 - 672
[14] Acute myeloid leukemia: leukemia stem cells write a prognostic signature
Emma J Gudgin
Brian JP Huntly
Stem Cell Research & Therapy, 2
[15] Venetoclax in adult acute myeloid leukemia
Hu, Mengci
Li, Wenzhe
Zhang, Youshan
Liang, Caixia
Tan, Jie
Wang, Ya
BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
[16] Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
Sheth, Anagha Inguva
Althoff, Mark J.
Tolison, Hunter
Engel, Krysta
Amaya, Maria L.
Krug, Anna E.
Young, Tracy N.
Minhajuddin, Mohammad
Pei, Shanshan
Patel, Sweta B.
Winters, Amanda
Miller, Regan
Shelton, Ian T.
St-Germain, Jonathan
Ling, Tianyi
Jones, Courtney L.
Raught, Brian
Gillen, Austin E.
Ransom, Monica
Staggs, Sarah
Smith, Clayton A.
Pollyea, Daniel A.
Stevens, Brett M.
Jordan, Craig T.
CANCER DISCOVERY, 2024, 14 (10) : 1922 - 1939
[17] Human acute myeloid leukemia stem cells: evolution of concept
Shin, Dong-Yeop
BLOOD RESEARCH, 2022, 57 (01) : 67 - 74
[18] Mitochondrial metabolism: powering new directions in acute myeloid leukemia
Stubbins, Ryan J.
Maksakov, Irina A.
Sanford, David S.
Rouhi, Arefeh
Kuchenbauer, Florian
LEUKEMIA & LYMPHOMA, 2021, 62 (10) : 2331 - 2341
[19] Metabolic Plasticity of Acute Myeloid Leukemia
Kreitz, Johanna
Schoenfeld, Christine
Seibert, Marcel
Stolp, Verena
Alshamleh, Islam
Oellerich, Thomas
Steffen, Bjoern
Schwalbe, Harald
Schnuetgen, Frank
Kurrle, Nina
Serve, Hubert
CELLS, 2019, 8 (08)
[20] Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells
Jones, Courtney L.
Stevens, Brett M.
Pollyea, Daniel A.
Culp-Hill, Rachel
Reisz, Julie A.
Nemkov, Travis
Gehrke, Sarah
Gamboni, Fabia
Krug, Anna
Winters, Amanda
Pei, Shanshan
Gustafson, Annika
Ye, Haobin
Inguva, Anagha
Amaya, Maria
Minhajuddin, Mohammad
Abbott, Diana
Becker, Michael W.
DeGregori, James
Smith, Clayton A.
D'Alessandro, Angelo
Jordan, Craig T.
CELL STEM CELL, 2020, 27 (05) : 748 - +

← 1 2 3 4 5 →